Warby Parker (WRBY) Change in Accured Expenses (2020 - 2026)
Warby Parker (WRBY) reported Change in Accured Expenses of -$469000.0 for Q1 2026, up 16.25% on a YoY basis from -$403440.9 in Q1 2025, and up 97.63% quarter-over-quarter from -$19.8 million in Q4 2025.
Warby Parker (WRBY) Change in Accured Expenses (2020 - 2026) Analysis & Trends
Warby Parker has reported Change in Accured Expenses for 7 years, with the latest figure at -$469000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 16.25% year-over-year to -$469000.0; the trailing twelve-month figure through Mar 2026 stood at -$2.6 million (down 371.87% YoY), and the FY2025 full-year result was -$2.7 million, down 2618.18% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$469000.0, up from -$19.8 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $16.8 million in Q3 2025, with the low at -$19.8 million in Q4 2025.
- Historically, Change in Accured Expenses has averaged -$83352.9 across 5 years, with a median of -$108000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses surged 221400.0% — and 2024, when it plunged 2488.42%.
- Warby Parker's Change in Accured Expenses stood at $2.2 million in 2022, then slumped by 111.33% to -$251000.0 in 2023, then slumped by 1026.29% to -$2.8 million in 2024, then sank by 601.2% to -$19.8 million in 2025, then surged by 97.63% to -$469000.0 in 2026.
- The last three Change in Accured Expenses figures came in at -$469000.0 (Q1 2026), -$19.8 million (Q4 2025), and $16.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -284.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -32.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.88 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -151.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 5.38 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Warby Parker | 3.11 Bn | 2.82 Bn | 131.04 Mn | -469,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -469,000.00 |
| Mar 31, 2026 | -469,000.00 |
| Dec 31, 2025 | -19.82 Mn |
| Dec 31, 2025 | -19.82 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Sep 30, 2025 | 16.77 Mn |
| Jun 30, 2025 | 925,000.00 |
| Jun 30, 2025 | 925,000.00 |
| Mar 31, 2025 | -560,000.00 |
| Mar 31, 2025 | -560,000.00 |
| Dec 31, 2024 | -2.83 Mn |
| Dec 31, 2024 | -2.83 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Sep 30, 2024 | -2.46 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.30 Mn |
| Mar 31, 2024 | -108,000.00 |
| Mar 31, 2024 | -108,000.00 |
| Dec 31, 2023 | -251,000.00 |
| Dec 31, 2023 | -251,000.00 |